Company intelligence / Profile preview

Eucatech

Ownership: Private
Development stage: Commercial

Overview

Eucatech develops, manufactures, and markets a range of CE-marked minimally invasive cardiovascular and endovascular devices. Their portfolio includes drug-eluting stents with biodegradable polymer coatings, balloon catheters, self-expanding nitinol stents with advanced coatings for peripheral arterial disease, and aspiration catheters. The company emphasizes innovation in biological coatings to improve safety and efficacy. Products are widely available internationally since 1997.

Therapeutic areas: Cardiovascular
Modalities: DeviceBiologic coating (for stents)
Industry: Implantable Medical Devices

Drug pipeline

3 assets

eucaLimus

Commercial

Indications: Coronary artery disease

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Eucatech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eucatech.

Explore the full profile